0001104659-20-001551.txt : 20200106
0001104659-20-001551.hdr.sgml : 20200106
20200106163557
ACCESSION NUMBER: 0001104659-20-001551
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200106
DATE AS OF CHANGE: 20200106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WESSON BRUCE F
CENTRAL INDEX KEY: 0001058190
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10113
FILM NUMBER: 20510221
MAIL ADDRESS:
STREET 2: 1827 PACIFIC ST
CITY: BROOKLYN
STATE: NY
ZIP: 11233
FORMER NAME:
FORMER CONFORMED NAME: WESSON BRUCE T
DATE OF NAME CHANGE: 19980319
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0000786947
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 110853640
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 616 N. NORTH COURT, SUITE 120
CITY: PALATINE
STATE: IL
ZIP: 60067
BUSINESS PHONE: 847-705-7709
MAIL ADDRESS:
STREET 1: 616 N. NORTH COURT, SUITE 120
STREET 2: .
CITY: PALATINE
STATE: IL
ZIP: 60067
FORMER COMPANY:
FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW
DATE OF NAME CHANGE: 19920703
4
1
tm201246d1_4.xml
OWNERSHIP DOCUMENT
X0306
4
2020-01-02
0
0000786947
ACURA PHARMACEUTICALS, INC
ACUR
0001058190
WESSON BRUCE F
C/O ACURA PHARMACEUTICALS, INC.
616 N. NORTH COURT, SUITE 120
PALATINE
IL
60067
1
0
0
0
Common Stock
2020-01-02
4
M
0
83333
A
603926
D
Restricted Stock Units (2017 Plan)
2020-01-02
4
M
0
83333
D
Common Stock
83333
0
D
Restricted Stock Units (2017 Plan)
2020-01-02
4
A
0
54790
A
Common Stock
54790
54790
D
Represents exchange of restricted stock units.
Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
Does not include Restricted Stock Units.
1 - for - 1
25% of Restricted Stock Units vested on March 31, 2019, 25% vested on June 30, 2019; 25% vested on September 30, 2019 and 25% vested on December 31, 2019. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
N/A
25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2020, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2021, or earlier upon a change of control.
/s/ Bruce Wesson
2020-01-06